Clinical Trial Update: Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing intravitreal bevacizumab to intravitreal triamcinolone for central retinal vein occlusion; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• Bevacizumab (bevacizumab)
• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Central Retinal Vein Occlusion | Phase 2 | Status: UNKNOWN